Snowden Capital Advisors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,400	Closed	-$212K	–	1243
2025 Q2	$212K	Sell	1,400 -182	-12%	-$24.3K	0.01%	1149
2025 Q1	$238K	Sell	1,582 -877	-36%	-$147K	0.01%	1090
2024 Q4	$454K	Sell	2,459 -406	-14%	-$78.2K	0.01%	811
2024 Q3	$564K	Buy	2,865 +954	+50%	+$198K	0.02%	718
2024 Q2	$395K	Sell	1,911 -204	-10%	-$46.2K	0.01%	862
2024 Q1	$573K	Sell	2,115 -219	-9%	-$52.3K	0.02%	701
2023 Q4	$552K	Buy	2,334 +218	+10%	+$42.9K	0.02%	659
2023 Q3	$415K	Sell	2,116 -169	-7%	-$34.7K	0.02%	728
2023 Q2	$480K	Buy	2,285 +391	+21%	+$77.8K	0.02%	755
2023 Q1	$382K	Buy	1,894 +239	+14%	+$54.2K	0.01%	846
2022 Q4	$361K	Sell	1,655 -187	-10%	-$40.8K	0.02%	852
2022 Q3	$362K	Buy	1,842 +136	+8%	+$29.4K	0.02%	805
2022 Q2	$365K	Sell	1,706 -717	-30%	-$175K	0.02%	775
2022 Q1	$688K	Buy	2,423 +2,062	+571%	+$636K	0.03%	537
2021 Q4	$136K	Sell	361 -1,619	-82%	-$629K	0.01%	759
2021 Q3	$817K	Buy	1,980 +178	+10%	+$73.9K	0.04%	407
2021 Q2	$667K	Buy	+1,802	New	+$602K	0.03%	461